trending Market Intelligence /marketintelligence/en/news-insights/trending/Aen4J6tV0XFgo1RQPP8n6Q2 content esgSubNav
In This List

GW Pharmaceuticals plans $225M offering of American depositary shares

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


GW Pharmaceuticals plans $225M offering of American depositary shares

GW Pharmaceuticals plc plans to sell $225 million of American depositary shares on the Nasdaq Global Market in an underwritten U.S. public offering.

The ADS represent ordinary shares of the company.

The company expects to grant the underwriters a 30-day option to buy up to an additional $33.75 million ADS at the offering price.

Goldman Sachs & Co. LLC, Morgan Stanley, Bank of America Merrill Lynch and Cowen are acting as joint book-running managers for the offering.